to page content
to site navigation
The Foundation's primary site.
Global news, events, and resources.
The national learning program for entrepreneurs.
A new approach to developing the next generation of high-growth firms.
Access to university research and innovation.
The Kauffman Foundation's charter school serving Kansas City.
Encouraging the aspirations of young people.
The platform for business plan competitions.
College preparation and access for urban youth in Kansas City.
A guide to Kauffman Foundation and partner resources, for aspiring entrepreneurs.
News and announcements from the Foundation.
From our vice president of Entrepreneurship.
From our vice president of Advancing Innovation.
News from Global Entrepreneurship Week
News about this education program for entrepreneurs.
Tweets for the eMed Community at Entrepreneurship.org
News from the Kauffman Labs program.
From our business plan competition service.
Contribute to the community seeking to improve entrepreneurship and innovation measurement.
A look at entrepreneurship from the Kauffman Foundation's Thom Ruhe.
Tracks research and policies that are accelerating economic growth and changing the world.
Brings to light various policies and initiatives to advance innovation and drive economic growth.
A selection of our videos
Take our video and audio with you.
Explore many of our publications.
Join the discussion on our LinkedIn site.
Join us on Google's social service.
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
In medical business news, a venture fund in Michigan has raised $15 million for investment in lifescience companies. SWMF LifeScience Venture Fund plans to raise $35 million more. Read more about this lifescience venture fund’s goals.
Whatever formula you use to calculate the market value of a business--assets, performance or other multiples--a good starting point may be all it provides. Here's why--along with the other factors that count.
Late-stage deals don't have much value for one outspoken venture capitalist. Read more about the reasons for his claim.
A healthcare business with a solution to the problem of catheter-related bloodstream infections is preparing to seek regulatory approvals for its product. Read more about this young company’s plans.
Medical device startups often are created out of the entrepreneur’s desire to solve a medical problem. It’s no different with Continental Dry Works and its male urinary incontinence product, The Pocket.
A North Carolina startup is taking on the problem of counterfeit drugs. The company’s technology embeds a tiny tag into the medicine itself that allows for identification and authentication to fight fraudulent pharmaceuticals.
A Medical Industry Valuation Laboratory is becoming known beyond Minnesota, even in China. Using a multi-faceted approach, the lab evaluates medical technologies and determines whether they should be commercialized.
Venture capitalists play a critical funding role, as entrepreneurial ventures move into the big leagues, but the price these investors extract is often too high. Entrepreneurs should consider the relationship analogous to marrying a mail-order bride and proceed accordingly, according to this comprehensive and entertaining article by two women who co-founded a software company. Tips include advising company owners to build trust with VCs and, until that is established, dealing with them in a way that allows for "a reasonable balance of power."
London's Alternative Investment Market (AIM) is a credible alternative for U.S. companies looking for a market listing. As with any approach to IPO, U.S. companies should research AIM's advantages and disadvantages for listing compared with U.S. stock markets.
Life sciences venture capital investing rose in the second quarter, due in part to increased exit activity. Read more for details on life sciences companies’ deals.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.